Evidence map›Paper›PMID 29301280›Full record

ReviewInternational journal of molecular sciences2018

Overview of the Microenvironment of Vasculature in Vascular Tone Regulation.

Yean Chun Loh, Chu Shan Tan, Yung Sing Ch'ng, Zhao Qin Yeap, Chiew Hoong Ng, Mun Fei Yam

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Nutrients · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Vascular Endothelial Cell Biology: An Update.International journal of molecular sciences · 2019
    Review
  13. Methamphetamine Use and Cardiovascular Disease.Arteriosclerosis, thrombosis, and vascular biology · 2019
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yean Chun LohDepartment of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden Gelugor 11800, Penang, Malaysia. lyc14_pha052@student.usm.my.ORCID 0000-0002-6274-9098
Chu Shan TanDepartment of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden Gelugor 11800, Penang, Malaysia. tcs14_pha053@student.usm.my.
Yung Sing Ch'ngDepartment of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden Gelugor 11800, Penang, Malaysia. cys14_pha057@student.usm.my.ORCID 0000-0003-4924-9651
Zhao Qin YeapDepartment of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden Gelugor 11800, Penang, Malaysia. edwardy3ap@gmail.com.
Chiew Hoong NgDepartment of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden Gelugor 11800, Penang, Malaysia. ngchiewhoong@student.usm.my.
Mun Fei YamDepartment of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden Gelugor 11800, Penang, Malaysia. yammunfei@usm.my.
Universiti Sains Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is asymptomatic and a well-known "silent killer", which can cause various concomitant diseases in human population after years of adherence. Although there are varieties of synthetic antihypertensive drugs available in current market, their relatively low efficacies and major application in only single drug therapy, as well as the undesired chronic adverse effects associated, has drawn the attention of worldwide scientists. According to the trend of antihypertensive drug evolution, the antihypertensive drugs used as primary treatment often change from time-to-time with the purpose of achieving the targeted blood pressure range. One of the major concerns that need to be accounted for here is that the signaling mechanism pathways involved in the vasculature during the vascular tone regulation should be clearly understood during the pharmacological research of antihypertensive drugs, either in vitro or in vivo. There are plenty of articles that discussed the signaling mechanism pathways mediated in vascular tone in isolated fragments instead of a whole comprehensive image. Therefore, the present review aims to summarize previous published vasculature-related studies and provide an overall depiction of each pathway including endothelium-derived relaxing factors, G-protein-coupled, enzyme-linked, and channel-linked receptors that occurred in the microenvironment of vasculature with a full schematic diagram on the ways their signals interact. Furthermore, the crucial vasodilative receptors that should be included in the mechanisms of actions study on vasodilatory effects of test compounds were suggested in the present review as well.

Indexed as

Cellular MicroenvironmentAnimalsBlood VesselsEndothelium, VascularHumansReceptors, Cell SurfaceVasodilationReceptors, Cell Surfaceblood vesselschannel-linked receptorsendothelium-derived relaxing factorsenzyme-linked receptorsG-protein-coupled receptorspharmacological toolsignaling mechanism pathwaysvascular tone

Identifiers

PMID29301280
PMCPMC5796069
OpenAlexW2785404011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.